{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:16:04Z","timestamp":1790957764359,"version":"4.1.0"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>\n                    Flavonoids, a diverse group of polyphenolic compounds found in various plant-based foods, have garnered attention for their potential in combating Hepatitis B Virus (HBV) infection. Flavonoids have demonstrated promising anti-HBV activities by interfering with multiple stages of the HBV life cycle, making them promising candidates for novel antiviral agents. Certain plant families, such as\n                    <jats:italic>Theaceae<\/jats:italic>\n                    ,\n                    <jats:italic>Asteraceae<\/jats:italic>\n                    ,\n                    <jats:italic>Lamiaceae<\/jats:italic>\n                    , and\n                    <jats:italic>Gentianaceae<\/jats:italic>\n                    , are of particular interest for their flavonoid-rich members with anti-HBV activities. Evidences, both\n                    <jats:italic>in vitro<\/jats:italic>\n                    and\n                    <jats:italic>in vivo<\/jats:italic>\n                    , supports the anti-HBV potential of flavonoids. These subsets of compound exert their anti-HBV effects through various mechanisms, including inhibiting viral entry, disrupting viral replication, modulating transcription factors, enhancing the immune response, and inducing autophagy. The antioxidant properties of flavonoids play a crucial role in modulating oxidative stress associated with HBV infection. Several flavonoids like epigallocatechin gallate (EGCG), proanthocyanidin (PAC), hexamethoxyflavone, wogonin, and baicalin have shown significant anti-HBV potential, holding promise as therapeutic agents. Synergistic effects between flavonoids and existing antiviral therapies offer a promising approach to enhance antiviral efficacy and reduce drug resistance. Challenges, including limited bioavailability, translation from preclinical studies to clinical practice, and understanding precise targets, need to be addressed. Future research should focus on clinical trials, combination therapies, and the development of flavonoid derivatives with improved bioavailability, and optimizing their effectiveness in managing chronic HBV infections.\n                  <\/jats:p>","DOI":"10.3389\/fcimb.2024.1356003","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:34:46Z","timestamp":1709166886000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["An overview of anti-Hepatitis B virus flavonoids and their mechanisms of action"],"prefix":"10.3389","volume":"14","author":[{"given":"Malihe","family":"Naderi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Salavatiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urvashee","family":"Gogoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Mohebbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27030903","article-title":"Potential antiviral action of alkaloids","volume":"27","author":"Abookleesh","year":"2022","journal-title":"Molecules"},{"key":"B2","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3945\/an.113.005603","article-title":"Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action","volume":"5","author":"Alam","year":"2014","journal-title":"Adv. Nutr."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.21037\/tgh","article-title":"Prevalence of hepatitis B virus among children of HBsAg-positive mothers in Hebron district, Palestine","volume":"5","author":"Al-Amleh","year":"2020","journal-title":"Transl. Gastroenterol. Hepatol."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6331630","article-title":"Therapeutic potential of isoflavones with an emphasis on daidzein","volume":"2021","author":"Alshehri","year":"2021","journal-title":"Oxid. Med. Cell Longev"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i36.6025","article-title":"Hepatitis B virus infection and hepatocellular carcinoma in sub-Saharan Africa: Implications for elimination of viral hepatitis by 2030","volume":"27","author":"Amponsah-Dacosta","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3390\/ph14040381","article-title":"Phytochemicals from plant foods as potential source of antiviral agents: an overview","volume":"14","author":"Behl","year":"2021","journal-title":"Pharmaceuticals"},{"key":"B7","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/J.BIOTECHADV.2018.01.009","article-title":"Biological activities of (\u2013)-epicatechin and (\u2013)-epicatechin-containing foods: Focus on cardiovascular and neuropsychological health","volume":"36","author":"Bernatova","year":"2018","journal-title":"Biotechnol. Adv."},{"key":"B8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/compounds3010005","article-title":"Polyphenols in health and disease: gut microbiota, bioaccessibility, and bioavailability","volume":"3","author":"Bi\u00e9","year":"2023","journal-title":"Compounds"},{"key":"B9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.fitote.2009.09.007","article-title":"Bioactive flavones and biflavones from Selaginella moellendorffii Hieron","volume":"81","author":"Cao","year":"2010","journal-title":"Fitoterapia"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28134982","article-title":"A review of classification, biosynthesis, biological activities and potential applications of flavonoids","volume":"28","author":"Chen","year":"2023","journal-title":"Molecules"},{"key":"B11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s12250-015-3584-5","article-title":"Inhibition of hepatitis B virus replication by quercetin in human hepatoma cell lines","volume":"30","author":"Cheng","year":"2015","journal-title":"Virol. Sin."},{"key":"B12","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/j.1440-1681.2005.04270.x","article-title":"Antiviral activities of extracts and selected pure constituents of Ocimum basilicum","volume":"32","author":"Chiang","year":"2005","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00011-017-1111-x","article-title":"Baicalin in flavocoxid may act against hepatitis B virus via a pro-inflammatory pathway","volume":"67","author":"Chirumbolo","year":"2018","journal-title":"Inflammation Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1177\/1934578X1200700205","article-title":"Antihepatitis B virus constituents of Solanum erianthum","volume":"7","author":"Chou","year":"2012","journal-title":"Nat. Prod. Commun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.3390\/molecules26175377","article-title":"Plant flavonoids: chemical characteristics and biological activity","volume":"26","author":"Dias","year":"2021","journal-title":"Molecules"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11051140","article-title":"Vertical transmission of hepatitis B virus\u2014An update","volume":"11","author":"di Filippo Villa","year":"2023","journal-title":"Microorganisms"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9966750","article-title":"Flavonols and flavones as potential anti-inflammatory, antioxidant, and antibacterial compounds","volume":"2022","author":"Do Socorro Chagas","year":"2022","journal-title":"Oxid. Med. Cell Longev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1080\/01635581.2013.770043","article-title":"Multitargeting and antimetastatic potentials of silibinin in human HepG-2 and PLC\/PRF\/5 hepatoma cells","volume":"65","author":"Ghasemi","year":"2013","journal-title":"Nutr. Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.antiviral.2007.01.002","article-title":"Anti-hepatitis B virus activity of wogonin in vitro and in vivo","volume":"74","author":"Guo","year":"2007","journal-title":"Antiviral Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.3748\/wjg.v17.i11.1507","article-title":"Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication-inducible cell line","volume":"17","author":"He","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/(SICI)1097-0010(20000515)80:7%3C1081::AID-JSFA566%3E3.0.CO;2-G","article-title":"Flavonols, flavones and flavanols\u2013nature, occurrence and dietary burden","volume":"80","author":"Hollman","year":"2000","journal-title":"J. Sci. Food. Agric."},{"key":"B22","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","article-title":"Global burden of hepatitis B virus: current status, missed opportunities and a call for action","volume":"20","author":"Hsu","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.bbrc.2019.12.099","article-title":"Nobiletin, a novel inhibitor, inhibits HBsAg production and hepatitis B virus replication","volume":"523","author":"Hu","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B24","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1055\/s-2000-9775","article-title":"Anti-hepatitis B virus effects of wogonin isolated from Scutellaria baicalensis","volume":"66","author":"Huang","year":"2000","journal-title":"Planta Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.antiviral.2013.11.007","article-title":"Antiviral activity of chemical compound isolated from Artemisia morrisonensis against hepatitis B virus in vitro","volume":"101","author":"Huang","year":"2014","journal-title":"Antiviral Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.antiviral.2014.09.009","article-title":"(\u2212)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes","volume":"111","author":"Huang","year":"2014","journal-title":"Antiviral Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.taap.2017.03.016","article-title":"Baicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAs","volume":"323","author":"Huang","year":"2017","journal-title":"Toxicol. Appl. Pharmacol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/CLD.732","article-title":"Epidemiology of hepatitis B virus infection in the United States","volume":"12","author":"Hyun Kim","year":"2018","journal-title":"Clin. Liver Dis. (Hoboken)"},{"key":"B29","first-page":"E71","article-title":"Antiviral activity of cananga odorata against hepatitis B virus","volume":"65","author":"Indrasetiawan","year":"2019","journal-title":"Kobe J. Med. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/S0140-6736(22)01468-4","article-title":"Hepatitis B","volume":"401","author":"Jeng","year":"2023","journal-title":"Lancet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3892\/mmr.2014.1925","article-title":"Taraxacum mongolicum extract exhibits a protective effect on hepatocytes and an antiviral effect against hepatitis B virus in animal and human cells","volume":"9","author":"Jia","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antiox9070609","article-title":"Antioxidant and anti-inflammatory effects of citrus flavonoid hesperetin: special focus on neurological disorders","volume":"9","author":"Khan","year":"2020","journal-title":"Antioxidants"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1080\/16546628.2017.1361779","article-title":"Anthocyanidins and anthocyanins: colored pigments as food, pharmaceutical ingredients, and the potential health benefits","volume":"61","author":"Khoo","year":"2017","journal-title":"Food Nutr. Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.3390\/antiox10071064","article-title":"Current perspectives on the beneficial effects of soybean isoflavones and their metabolites for humans","volume":"10","author":"Kim","year":"2021","journal-title":"Antioxidants"},{"key":"B35","doi-asserted-by":"crossref","first-page":"6739","DOI":"10.1016\/j.bmcl.2007.10.046","article-title":"Isolation of quinic acid derivatives and flavonoids from the aerial parts of Lactuca indica L. and their hepatoprotective activity in vitro","volume":"17","author":"Kim","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-018-2316-4","article-title":"Epigallocatechin gallate inhibits hepatitis B virus infection in human liver chimeric mice","volume":"18","author":"Lai","year":"2018","journal-title":"BMC Complement Altern. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3390\/molecules21030336","article-title":"New anti-HBV C-boivinopyranosyl flavones from alternanthera philoxeroides","volume":"21","author":"Li","year":"2016","journal-title":"Molecules"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-80709-z","article-title":"Effect of silibinin capsules combined with lifestyle modification on hepatic steatosis in patients with chronic hepatitis B","volume":"11","author":"Lv","year":"2021","journal-title":"Sci. Rep."},{"key":"B39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.virol.2017.04.002","article-title":"Discovery and mechanism of action of Novel Baicalein modified derivatives as potent antihepatitis agent","volume":"507","author":"Ma","year":"2017","journal-title":"Virology"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.81070","article-title":"The forgotten people: Hepatitis B virus (HBV) infection as a priority for the inclusion health agenda","volume":"12","author":"Martyn","year":"2023","journal-title":"Elife"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.3390\/nu15133016","article-title":"Food anthocyanins: malvidin and its glycosides as promising antioxidant and anti-inflammatory agents with potential health benefits","volume":"15","author":"Merecz-Sadowska","year":"2023","journal-title":"Nutrients"},{"key":"B42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000512140","article-title":"Havachoobe (Onosma dichroanthum boiss) root extract decreases the hepatitis B virus surface antigen secretion in the PLC\/PRF\/5 cell line","volume":"64","author":"Mohebbi","year":"2021","journal-title":"Intervirology"},{"key":"B43","article-title":"QSAR Modeling of a Ligand-Based Pharmacophore Derived from Hepatitis B Virus Surface Antigen Inhibitors","author":"Mohebbi","year":"2022","journal-title":"Acta Microbiol Bulg"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0285941","article-title":"A fragment-based drug discovery developed on ciclopirox for inhibition of Hepatitis B virus core protein: An in silico study","volume":"18","author":"Mohebbi","year":"2023","journal-title":"PloS One"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00662","article-title":"An overview of hepatitis B virus surface antigen secretion inhibitors","volume":"9","author":"Mohebbi","year":"2018","journal-title":"Front. Microbiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s13337-016-0333-9","article-title":"Prediction of HBF-0259 interactions with hepatitis B Virus receptors and surface antigen secretory factors","volume":"27","author":"Mohebbi","year":"2016","journal-title":"Virusdisease"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2022.199036","article-title":"Association of HLADQ-B1 polymorphisms in three generations of chronic hepatitis B patients","volume":"325","author":"Naderi","year":"2023","journal-title":"Virus Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1007\/s11262-023-02012-z","article-title":"Mutations in the S gene of hepatitis B virus in three generations of patients with chronic hepatitis B","volume":"59","author":"Naderi","year":"2023","journal-title":"Virus Genes"},{"key":"B49","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2217\/FVL-2022-0216","article-title":"Clinical and virological aspects of core and pre-core mutations in three generations of chronic hepatitis B virus patients","volume":"18","author":"Naderi","year":"2023","journal-title":"Future Virol."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/nu12092534","article-title":"Antiviral properties of flavonoids and delivery strategies","volume":"12","author":"Ninfali","year":"2020","journal-title":"Nutrients"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1017\/JNS.2016.41","article-title":"Flavonoids: an overview","volume":"5","author":"Panche","year":"2016","journal-title":"J. Nutr. Sci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"29100","DOI":"10.1021\/acsomega.1c04320","article-title":"Novel anti-hepatitis B virus activity of euphorbia schimperi and its quercetin and kaempferol derivatives","volume":"6","author":"Parvez","year":"2021","journal-title":"ACS Omega"},{"key":"B53","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00011-017-1099-2","article-title":"Flavocoxid exerts a potent antiviral effect against hepatitis B virus","volume":"67","author":"Pollicino","year":"2018","journal-title":"Inflammation Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s13337-018-00510-5","article-title":"Hepatitis B virus reverse transcriptase polymorphisms between treated and treatment-na\u00efve chronically infected patients","volume":"30","author":"Rezanezhadi","year":"2019","journal-title":"Virusdisease"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1051751","article-title":"Role of bioactive compounds in the treatment of hepatitis: A review","volume":"13","author":"Roy","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061305","article-title":"The therapeutic potential of apigenin","volume":"20","author":"Salehi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.3109\/03639045.2016.1173051","article-title":"Hyperoside nanocrystals for HBV treatment: process optimization, in vitro and in vivo evaluation","volume":"42","author":"Shen","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"key":"B58","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2021.05.007","article-title":"Anti-HBV therapeutic potential of small molecule 3, 5, 6, 7, 3\u2032, 4\u2032-Hexamethoxyflavone in vitro and in vivo","volume":"560","author":"Tan","year":"2021","journal-title":"Virology"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0197664","article-title":"Rosmarinic acid is a novel inhibitor for hepatitis b virus replication targeting viral epsilon RNA-polymerase interaction","volume":"13","author":"Tsukamoto","year":"2018","journal-title":"PloS One"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1002\/hep.28952","article-title":"A new class of hepatitis B and D virus entry inhibitors, proanthocyanidin and its analogs, that directly act on the viral large surface proteins","volume":"65","author":"Tsukuda","year":"2017","journal-title":"Hepatology"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.fitote.2013.06.002","article-title":"Three new secoiridoids, swermacrolactones A\u2013C and anti-hepatitis B virus activity from Swertia macrosperma","volume":"89","author":"Wang","year":"2013","journal-title":"Fitoterapia"},{"key":"B62","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41401-019-0302-0","article-title":"ERK1\/2-HNF4\u03b1 axis is involved in epigallocatechin-3-gallate inhibition of HBV replication","volume":"41","author":"Wang","year":"2020","journal-title":"Acta Pharmacol. Sin"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1186\/s12992-023-00922-z","article-title":"Global burden of hepatitis B attributable to modifiable risk factors from 1990 to 2019: a growing contribution and its association with socioeconomic status","volume":"19","author":"Wang","year":"2023","journal-title":"Global Health"},{"key":"B64","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/j.1745-7254.2007.00510.x","article-title":"In vivo and in vitro antiviral activity of hyperoside extracted from Abelmoschus manihot (L) medik","volume":"28","author":"Wu","year":"2007","journal-title":"Acta Pharmacol Sin"},{"key":"B65","doi-asserted-by":"publisher","first-page":"115131","DOI":"10.1016\/j.taap.2020.115131","article-title":"Baicalin down-regulating hepatitis B virus transcription depends on the liver-specific HNF4\u03b1-HNF1\u03b1 axis","volume":"403","author":"Xia","year":"2020","journal-title":"Toxicol Appl Pharmacol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"112787","DOI":"10.1016\/j.jep.2020.112787","article-title":"Anti-hepatitis B virus activity of swertisin isolated from Iris tectorum Maxim","volume":"257","author":"Xu","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s11418-016-0980-6","article-title":"Epigallocatechin gallate inhibits hepatitis B virus via farnesoid X receptor alpha","volume":"70","author":"Xu","year":"2016","journal-title":"J. Nat. Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1080\/10837450.2019.1646757","article-title":"Development and in vivo evaluation of baicalin-loaded W\/O nanoemulsion for lymphatic absorption","volume":"24","author":"Xu","year":"2019","journal-title":"Pharm. Dev. Technol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/cbdv.200890130","article-title":"Biflavanones, flavonoids, and coumarins from the roots of Stellera chamaejasme and their antiviral effect on hepatits B virus","volume":"5","author":"Yang","year":"2008","journal-title":"Chem. Biodivers"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-020-00309-4","article-title":"In vitro inhibition effects of hepatitis B virus by dandelion and taraxasterol","volume":"15","author":"Yang","year":"2020","journal-title":"Infect. Agent Cancer"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-3542(98)00033-3","article-title":"Robustaflavone, a potential non-nucleoside anti-hepatitis B agent","volume":"39","author":"Zembower","year":"1998","journal-title":"Antiviral Res."},{"key":"B72","article-title":"Icaritin inhibits the expression of alpha-fetoprotein in hepatitis B virus-infected hepatoma cell lines through post-transcriptional regulation","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00956","article-title":"Protective mechanisms of quercetin against myocardial ischemia reperfusion injury","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Physiol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ejmech.2012.09.017","article-title":"Anti-hepatitis B virus and anti-cancer activities of novel isoflavone analogs","volume":"62","author":"Zhang","year":"2013","journal-title":"Eur. J. Med. Chem."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1356003\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:34:52Z","timestamp":1709166892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1356003\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,29]]},"references-count":74,"alternative-id":["10.3389\/fcimb.2024.1356003"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2024.1356003","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,29]]},"article-number":"1356003"}}